Juventas Therapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.juventasinc.com
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
- Conditions
- Peripheral Arterial Disease
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Juventas Therapeutics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT02544204
- Locations
- 🇺🇸
Cardiovascular Associates of the Southeast, Birmingham, Alabama, United States
🇺🇸UC Davis, Davis, California, United States
🇺🇸Cedars-Sinai Heart Institute, Los Angeles, California, United States
Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203
- Conditions
- Ischemic Heart Failure
- First Posted Date
- 2014-04-16
- Last Posted Date
- 2014-04-16
- Lead Sponsor
- Juventas Therapeutics, Inc.
- Target Recruit Count
- 165
- Registration Number
- NCT02115568
- Locations
- 🇺🇸
Cardiology, P.C., Birmingham, Alabama, United States
🇺🇸University of Florida, Gainsville, Florida, United States
🇺🇸Pepin Heart Institute, Tampa, Florida, United States
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
- Conditions
- Ischemic Heart Failure
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2014-10-23
- Lead Sponsor
- Juventas Therapeutics, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT01961726
- Locations
- 🇺🇸
Cardiology, P.C., Birmingham, Alabama, United States
🇺🇸University of Florida, Gainsville, Florida, United States
🇺🇸The Carl and Edyth Lindner Center for Research & Education at The Christ Hospital, Cincinnati, Ohio, United States
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
- Conditions
- Ischemic Heart Failure
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2014-02-07
- Lead Sponsor
- Juventas Therapeutics, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01643590
- Locations
- 🇺🇸
Cardiology PC, Birmingham, Alabama, United States
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸Pepin Heart Institute, Tampa, Florida, United States
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb Ischemia
- Conditions
- Critical Limb Ischemia
- First Posted Date
- 2011-08-05
- Last Posted Date
- 2014-10-23
- Lead Sponsor
- Juventas Therapeutics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT01410331
- Locations
- 🇺🇸
Cardiology PC, Birmingham, Alabama, United States
🇺🇸Northwestern Memorial Hospital/Northwestern University, Chicago, Illinois, United States
🇺🇸Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States
- Prev
- 1
- 2
- Next